Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Antonio Guterres Re-elected as UN Secretary-General for Second Five-Year Term

After a unanimous recommendation by the Security Council,…
Read more

IRS Determines Biblical Values to be ‘Exclusively Republican’

After denying tax-exempt status to a Texas organization called…
Read more

Cold War Warning

Angela Merkel's successor has warned of the dangers of a…
Read more